首页> 外文OA文献 >PND55 Disease Burden Among Patients with Multiple Sclerosis Not Receiving Disease Modifying Treatments in Europe and the United States

【2h】

PND55 Disease Burden Among Patients with Multiple Sclerosis Not Receiving Disease Modifying Treatments in Europe and the United States

机译：在欧洲和美国，多发性硬化症患者中PND55疾病负担未接受疾病改良治疗

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Narayanan S.; Khan H.; Gabriele S.; White J.;
展开▼
作者单位

展开▼
年度 2013
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Quality of Life of Patients Receiving Long-Term Treatment with First-Line Multiple Sclerosis Disease-Modifying Drugs: Results of a Russian Multicenter Study Using the MusiQol Questionnaire [J] . O. V. Boiko, E. V. Popova, A. N. Boiko Neuroscience and behavioral physiology . 2015,第3期

机译：接受一线多发性硬化症疾病修饰药物长期治疗的患者的生活质量：使用MusiQol问卷进行的俄罗斯多中心研究的结果
2. A 12-month prospective, observational study evaluating the impact of disease-modifying treatment on emotional burden in recently-diagnosed multiple sclerosis patients: The POSIDONIA study [J] . Montanari Enrico, Rottoli Mariarosa, Maimone Davide, Journal of the Neurological Sciences: Official Bulletin of the World Federation of Neurology . 2016,第Null期

机译：一项为期12个月的前瞻性观察性研究，评估了疾病改善疗法对最近诊断为多发性硬化症患者的情绪负担的影响：POSIDONIA研究
3. An epidemiological study on the course of disease and therapeutic considerations in relapsing–remitting multiple sclerosis patients receiving injectable first-line disease-modifying therapies in Germany (EPIDEM) [J] . Stephan Schmidt, Jürgen Koehler, Christine Winterstein, Therapeutic advances in neurological disorders. . 2018,第11期

机译：关于在德国接受可注射的一线疾病修饰疗法的复发缓解型多发性硬化症患者的病程流行病学研究和治疗注意事项（EPIDEM）
4. Predicting Future Disease Activity and Treatment Responders for Multiple Sclerosis Patients Using a Bag-of-Lesions Brain Representation [C] . Andrew Doyle, Doina Precup, Douglas L. Arnold, International conference on medical imaging computing and computer-assisted intervention . 2017

机译：使用病变袋大脑表示法预测多发性硬化症患者的未来疾病活动和治疗反应者
5. Imaging Informatics-Based Electronic Patient Record and Analysis System for Multiple Sclerosis Research, Treatment, and Disease Tracking [D] . Ma, Kevin C. 2018

机译：基于信息学的电子患者记录和分析系统，用于多发性硬化研究，治疗和疾病跟踪
6. Productivity Loss and Associated Costs Among Employed Patients Receiving Disease-Modifying Treatment for Multiple Sclerosis [O] . Machaon Bonafede, Rina Mehta, Gilwan Kim, 2021

机译：接受多发性硬化症的疾病改性治疗的使用患者的生产率丧失和相关成本
7. PND56 Disease Burden Among Patients with Secondary Progressive Multiple Sclerosis Currently Using Disease Modifying Treatments in Europe Union and the United States [O] . Narayanan S., Khan H., Gabriele S., 2013

机译：在欧洲联盟和美国，目前正在使用疾病改良治疗的继发性进行性多发性硬化症患者中，PND56疾病负担

PND55 Disease Burden Among Patients with Multiple Sclerosis Not Receiving Disease Modifying Treatments in Europe and the United States

著录项

引文网络

相似文献

相关主题

期刊订阅